Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11274402.
- Also identified by PMC identifier 31139.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by endocrine tumors of parathyroids, pancreatic islets, and anterior pituitary. The MEN1 gene encodes a nuclear protein called menin. In MEN1 carriers inactivating mutations give rise to a truncated product consistent with menin acting as a tumor suppressor gene. However, the role of menin in tumorigenesis and its physiological functions are not known. Here, we show that menin inactivation by antisense RNA antagonizes transforming growth factor type beta-mediated cell growth inhibition. Menin interacts with Smad3, and antisense menin suppresses transforming growth factor type beta-induced and Smad3-induced transcriptional activity by inhibiting Smad3/4-DNA binding at specific transcriptional regulatory sites. These results implicate a mechanism of tumorigenesis by menin inactivation.
Medical subject headings
- DNA-Binding Proteins
- Neoplasm Proteins
- Proto-Oncogene Proteins
- RNA, Antisense
- Trans-Activators
- Transforming Growth Factor beta